Page last updated: 2024-10-19

melatonin and Cephalgia Syndromes

melatonin has been researched along with Cephalgia Syndromes in 10 studies

Research Excerpts

ExcerptRelevanceReference
"There is increasing evidence that headache disorders are connected with melatonin secretion and pineal function."8.83Potential therapeutic use of melatonin in migraine and other headache disorders. ( Cavalheiro, EA; Masruha, MR; Moreira-Filho, CA; Peres, MF; Zukerman, E, 2006)
"Melatonin plays an important role in headache disorders, offering new avenues for studying their pathophysiology and treatment."6.43Melatonin, the pineal gland and their implications for headache disorders. ( Peres, MF, 2005)
"Melatonin intervention has no significant influence on well-being, sleepiness, sleep quality, pain intensity after 1 and 3 hours, headache, depression, and dizziness for laparoscopic cholecystectomy."5.01The Influence of Melatonin on Sleep Quality After Laparoscopic Cholecystectomy: A Meta-Analysis of Randomized Controlled Trials. ( Wang, Y; Xu, H; Yang, J; Zhang, J, 2019)
"There is increasing evidence that headache disorders are connected with melatonin secretion and pineal function."4.83Potential therapeutic use of melatonin in migraine and other headache disorders. ( Cavalheiro, EA; Masruha, MR; Moreira-Filho, CA; Peres, MF; Zukerman, E, 2006)
"Models of sleep physiology and insomnia are discussed, along with the potential implications for the chronification of migraine and tension-type headache."2.48Chronic headaches and insomnia: working toward a biobehavioral model. ( Ong, JC; Park, M, 2012)
"Melatonin is believed to be a significant element in migraine and in other headache disorders, which has implications for treatment."2.46Headache endocrinological aspects. ( Prieto Peres, MF; Valença, MM, 2010)
"Melatonin plays an important role in headache disorders, offering new avenues for studying their pathophysiology and treatment."2.43Melatonin, the pineal gland and their implications for headache disorders. ( Peres, MF, 2005)
"Several theories attempt to explain migraine etiology."2.41The therapeutic potential of melatonin in migraines and other headache types. ( Gagnier, JJ, 2001)
"Frequent and recurrent migraine headaches can, over time, pose the additional risks of stroke, brain damage, heart failure and attention deficit."1.33A chronopharmacological preventive treatment for sleep-related migraine headaches and chronic morning headaches: Nitric oxide supersensitivity can cause sleep-related headaches in a subset of patients. ( Eli, R; Fasciano, JA, 2006)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, J1
Wang, Y1
Xu, H1
Yang, J1
Rozen, TD2
Beams, JL1
Ulas, UH1
Korkmaz, A1
Karadas, O1
Odabasi, Z1
Reiter, RJ1
Prieto Peres, MF1
Valença, MM1
Ong, JC1
Park, M1
Peres, MF3
Eli, R1
Fasciano, JA1
Masruha, MR1
Zukerman, E1
Moreira-Filho, CA1
Cavalheiro, EA1
Stiles, MA1
Oshinsky, M1
Gagnier, JJ1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches[NCT00391755]Phase 44 participants (Actual)Interventional2006-10-31Terminated (stopped due to Failure to recruit necessary number of patients.)
"Melatonin for Migraine Prevention in Adolescents: A Pilot Remote Trial: The BRAiN-M Study"[NCT02344316]Phase 231 participants (Actual)Interventional2015-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Headache Diary Compliance Rate

Number of participants that had ≥85% headache diary compliance during weeks 12-16 of the study. (NCT02344316)
Timeframe: Weeks 12-16 of the study

InterventionParticipants (Count of Participants)
Melatonin11
Placebo10

Medication Adherence as Measured by Number of Openings Per Participant

eCAP tack caps will be used to measure medication adherence and the number of openings will be recorded per participant. (NCT02344316)
Timeframe: "during the At Home Active Study Period or Weeks 5-16"

InterventionMean Number of Openings (Mean)
Melatonin39
Placebo60

Number of Migraine/Migrainous Days Per 28 Day Period

Number of Migraine/Migrainous Days Per 28 Day Period in melatonin group and placebo group as measured using an online/mobile device headache diary. (NCT02344316)
Timeframe: final 4 weeks of treatment

Interventiondays (Mean)
Melatonin3.6
Placebo4.9

Number of Minutes to Sleep Onset

Number of minutes to sleep onset as measured by a FitBit. (NCT02344316)
Timeframe: 16 weeks

Interventionminutes (Mean)
Melatonin15.2
Placebo17.2

Reviews

6 reviews available for melatonin and Cephalgia Syndromes

ArticleYear
The Influence of Melatonin on Sleep Quality After Laparoscopic Cholecystectomy: A Meta-Analysis of Randomized Controlled Trials.
    Surgical laparoscopy, endoscopy & percutaneous techniques, 2019, Volume: 29, Issue:1

    Topics: Central Nervous System Depressants; Cholecystectomy, Laparoscopic; Depression; Dizziness; Headache D

2019
Headache endocrinological aspects.
    Handbook of clinical neurology, 2010, Volume: 97

    Topics: Animals; Circadian Rhythm; Headache; Headache Disorders; Headache Disorders, Primary; Humans; Melato

2010
Chronic headaches and insomnia: working toward a biobehavioral model.
    Cephalalgia : an international journal of headache, 2012, Volume: 32, Issue:14

    Topics: Actigraphy; Adaptation, Psychological; Caffeine; Chronobiology Phenomena; Comorbidity; Headache Diso

2012
Melatonin, the pineal gland and their implications for headache disorders.
    Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:6

    Topics: Circadian Rhythm; Headache Disorders; Humans; Melatonin; Pineal Gland; Randomized Controlled Trials

2005
Potential therapeutic use of melatonin in migraine and other headache disorders.
    Expert opinion on investigational drugs, 2006, Volume: 15, Issue:4

    Topics: Animals; Headache Disorders; Humans; Melatonin; Migraine Disorders

2006
The therapeutic potential of melatonin in migraines and other headache types.
    Alternative medicine review : a journal of clinical therapeutic, 2001, Volume: 6, Issue:4

    Topics: Female; Headache Disorders; Humans; Male; Melatonin; Migraine Disorders; Pineal Gland

2001

Other Studies

4 other studies available for melatonin and Cephalgia Syndromes

ArticleYear
A case of post-traumatic LASH syndrome responsive to indomethacin and melatonin (a man with a unique triad of indomethacin-responsive trigeminal autonomic cephalalgias).
    Cephalalgia : an international journal of headache, 2015, Volume: 35, Issue:5

    Topics: Accidents, Traffic; Adult; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System Depressan

2015
Sunrise-related headache: case report.
    Cephalalgia : an international journal of headache, 2010, Volume: 30, Issue:1

    Topics: Adult; Cerebral Infarction; Circadian Rhythm; Cysts; Headache Disorders; Humans; Hypothalamus; Magne

2010
A chronopharmacological preventive treatment for sleep-related migraine headaches and chronic morning headaches: Nitric oxide supersensitivity can cause sleep-related headaches in a subset of patients.
    Medical hypotheses, 2006, Volume: 66, Issue:3

    Topics: Antioxidants; Headache Disorders; Humans; Hydrocortisone; Melatonin; Migraine Disorders; Moclobemide

2006
Remitting form of hemicrania continua with seasonal pattern.
    Headache, 2001, Volume: 41, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Female; Headache Disorders; Humans; Indomethacin; Melatonin

2001